Abstract:Circulation Research, Ahead of Print. BACKGROUND:Hypertrophic cardiomyopathy (HCM) is the most prevalent monogenic heart disorder. However, the pathogenesis of HCM, especially its nongenetic mechanisms, remains largely unclear. TFs (transcription factors) are known to be involved in various biological processes including cell growth. We hypothesized that Sp1 (specificity protein 1), the first purified TF in mammals, plays a role in the cardiomyocyte growth and cardiac hypertrophy of HCM.METHODS:Cardiac-specific conditional knockout of Sp1 mice were constructed to investigate the role of SP1 in the heart. The echocardiography, histochemical experiment, and transmission electron microscope were performed to analyze the cardiac phenotypes of cardiac-specific conditional knockout of Sp1 mice. RNA sequencing, chromatin immunoprecipitation sequencing, and adeno-associated virus experiments in vivo were performed to explore the downstream molecules of SP1. To examine the therapeutic effect of SP1 on HCM, an SP1 overexpression vector was constructed and injected into the mutant allele of Myh6 R404Q/+ (Myh6c. 1211C>T) HCM mice. The human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) from a patient with HCM were used to detect the potential therapeutic effects of SP1 in human HCM.RESULTS:The cardiac-specific conditional knockout of Sp1 mice developed a typical HCM phenotype, displaying overt myocardial hypertrophy, interstitial fibrosis, and disordered myofilament. In addition, Sp1 knockdown dramatically increased the cell area of hiPSC-CMs and caused intracellular myofibrillar disorganization, which was similar to the hypertrophic cardiomyocytes of HCM. Mechanistically,Tuft1was identified as the key target gene of SP1. The hypertrophic phenotypes induced by Sp1 knockdown in both hiPSC-CMs and mice could be rescued by TUFT1 (tuftelin 1) overexpression. Furthermore, SP1 overexpression suppressed the development of HCM in the mutant allele of Myh6 R404Q/+ mice and also reversed the hypertrophic phenotype of HCM hiPSC-CMs.CONCLUSIONS:Our study demonstrates that SP1 deficiency leads to HCM. SP1 overexpression exhibits significant therapeutic effects on both HCM mice and HCM hiPSC-CMs, suggesting that SP1 could be a potential intervention target for HCM.

Abstract 836: Downregulation of Microrna-1/Microrna-133 and Overexpression of Sp1 Activates Re-expression of Pacemaker Channel Genes HCN2 and HCN4 in Hypertrophic Heart

Down-regulation of miR-1/miR-133 Contributes to Re-expression of Pacemaker Channel Genes HCN2 and HCN4 in Hypertrophic Heart,

Transcriptional Control Of Pacemaker Channel Genes Hcn2 And Hcn4 By Sp1 And Implications In Re-Expression Of These Genes In Hypertrophied Myocytes

Cardiac Hypertrophy and Dysfunction Induced by Overexpression of Mir-214 in Vivo

Inhibition of TRPC1 Prevents Cardiac Hypertrophy Via NF-κB Signaling Pathway in Human Pluripotent Stem Cell-Derived Cardiomyocytes.

Sympathoexcitation in Rats with Chronic Heart Failure Depends on Homeobox D10 and MicroRNA-7b Inhibiting GABBR1 Translation in Paraventricular Nucleus

Retracted: Transcriptional Activation by Stimulating Protein 1 and Post‐transcriptional Repression by Muscle‐specific Micrornas of IKs‐encoding Genes and Potential Implications in Regional Heterogeneity of Their Expressions

Microrna-340-5p Functions Downstream Of Cardiotrophin-1 To Regulate Cardiac Eccentric Hypertrophy And Heart Failure Via Target Gene Dystrophin

Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications

Mir-139-5p Inhibits Isoproterenol-Induced Cardiac Hypertrophy by Targetting C-Jun

<i>HCN2</i> and <i>TBX3</i> Reprogram Human-Induced Pluripotent Stem Cells-Derived Cardiomyocytes into Pacemaker-Like Cells

Deficiency of Transcription Factor SP1 Contributes to Hypertrophic Cardiomyopathy

Abstract 15963: Microrna Biophysically Modulates Cardiac Physiology Via Directly Binding to Ion Channel

MiR-466h-5p Induces Expression of Myocardin with Complementary Promoter Sequences

Retracted: Novel Approaches For Gene-Specific Interference Manipulating Actions Of Via Micrornas: Examination On The Pacemaker Channel Genes Hcn2 And Hcn4 (Retracted Article. See Vol. 227, Pg. 877, 2012)

Microrna-1 Negatively Regulates Expression of the Hypertrophy-Associated Calmodulin and Mef2a Genes

Identification of Key Small Non‐Coding MicroRNAs Controlling Pacemaker Mechanisms in the Human Sinus Node

Silencing miR-370-3p rescues funny current and sinus node function in heart failure

An Intragenic Srf-Dependent Regulatory Motif Directs Cardiac-Specific Microrna-1-1/133a-2 Expression

Abstract 835: Downregulation of Cardiomyocyte-enriched Micrornas Contributes to Altered Gene Expression in Heart Failure

MicroRNA-133a Protects Against Myocardial Fibrosis and Modulates Electrical Repolarization Without Affecting Hypertrophy in Pressure-Overloaded Adult Hearts.